287 related articles for article (PubMed ID: 9425913)
1. Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors.
Bernardi M; Calandra S; Colantoni A; Trevisani F; Raimondo ML; Sica G; Schepis F; Mandini M; Simoni P; Contin M; Raimondo G
Hepatology; 1998 Jan; 27(1):28-34. PubMed ID: 9425913
[TBL] [Abstract][Full Text] [Related]
2. [Clinical investigation of Q-T prolongation in hepatic cirrhosis].
Li L; Liu HR; Shu JL; Xi XP; Wang Y
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2717-8. PubMed ID: 18167253
[TBL] [Abstract][Full Text] [Related]
3. QT interval analysis in patients with chronic liver disease: a prospective study.
Kosar F; Ates F; Sahin I; Karincaoglu M; Yildirim B
Angiology; 2007; 58(2):218-24. PubMed ID: 17495272
[TBL] [Abstract][Full Text] [Related]
4. Prolonged Q-T(c) interval in mild portal hypertensive cirrhosis.
Ytting H; Henriksen JH; Fuglsang S; Bendtsen F; Møller S
J Hepatol; 2005 Oct; 43(4):637-44. PubMed ID: 16083986
[TBL] [Abstract][Full Text] [Related]
5. Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease.
Mohamed R; Forsey PR; Davies MK; Neuberger JM
Hepatology; 1996 May; 23(5):1128-34. PubMed ID: 8621144
[TBL] [Abstract][Full Text] [Related]
6. [Cisapride does not modify prolonged Q-T interval in patients with liver cirrhosis].
Quera R; Madrid AM; Ugalde H; Defilippi C
Rev Med Chil; 2000 Aug; 128(8):847-52. PubMed ID: 11129545
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis.
Zambruni A; Trevisani F; Di Micoli A; Savelli F; Berzigotti A; Bracci E; Caraceni P; Domenicali M; Felline P; Zoli M; Bernardi M
J Hepatol; 2008 Mar; 48(3):415-21. PubMed ID: 18194821
[TBL] [Abstract][Full Text] [Related]
8. Q-T interval (QT(C)) in patients with cirrhosis: relation to vasoactive peptides and heart rate.
Henriksen JH; Gülberg V; Fuglsang S; Schifter S; Bendtsen F; Gerbes AL; Møller S
Scand J Clin Lab Invest; 2007; 67(6):643-53. PubMed ID: 17852825
[TBL] [Abstract][Full Text] [Related]
9. Diurnal variation and dispersion in QT interval in cirrhosis: relation to haemodynamic changes.
Hansen S; Møller S; Bendtsen F; Jensen G; Henriksen JH
J Hepatol; 2007 Sep; 47(3):373-80. PubMed ID: 17459513
[TBL] [Abstract][Full Text] [Related]
10. Is azithromycin treatment associated with prolongation of the Q-Tc interval?
Strle F; Maraspin V
Wien Klin Wochenschr; 2002 Jun; 114(10-11):396-9. PubMed ID: 12708094
[TBL] [Abstract][Full Text] [Related]
11. Q-T interval prolongation in liver cirrhosis. Reversibility after orthotopic liver transplantation.
Finucci G; Lunardi F; Sacerdoti D; Volpin R; Bortoluzzi A; Bombonato G; Angeli P; Gatta A
Jpn Heart J; 1998 May; 39(3):321-9. PubMed ID: 9711183
[TBL] [Abstract][Full Text] [Related]
12. Corrected QT interval and QT dispersion in cirrhotic patients before and after liver transplantation.
Zamirian M; Tavassoli M; Aghasadeghi K
Arch Iran Med; 2012 Jun; 15(6):375-7. PubMed ID: 22642249
[TBL] [Abstract][Full Text] [Related]
13. Autonomic function in chronic liver disease assessed by Heart Rate Variability Study.
Coelho L; Saraiva S; Guimaräes H; Freitas D; Providência LA
Rev Port Cardiol; 2001 Jan; 20(1):25-36. PubMed ID: 11291332
[TBL] [Abstract][Full Text] [Related]
14. Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients.
Nordin C; Kohli A; Beca S; Zaharia V; Grant T; Leider J; Marantz P
J Electrocardiol; 2006 Apr; 39(2):199-205. PubMed ID: 16580420
[TBL] [Abstract][Full Text] [Related]
15. Implication of inflammation-related cytokines in the natural history of liver cirrhosis.
Girón-González JA; Martínez-Sierra C; Rodriguez-Ramos C; Macías MA; Rendón P; Díaz F; Fernández-Gutiérrez C; Martín-Herrera L
Liver Int; 2004 Oct; 24(5):437-45. PubMed ID: 15482340
[TBL] [Abstract][Full Text] [Related]
16. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
[TBL] [Abstract][Full Text] [Related]
17. Effect of propranolol on the relationship between QT interval and vagal modulation of heart rate variability in cirrhotic patients awaiting liver transplantation.
Kim YK; Hwang GS; Shin WJ; Bang JY; Cho SK; Han SM
Transplant Proc; 2011 Jun; 43(5):1654-9. PubMed ID: 21693252
[TBL] [Abstract][Full Text] [Related]
18. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites.
Alam I; Bass NM; Bacchetti P; Gee L; Rockey DC
Am J Gastroenterol; 2000 Jan; 95(1):199-203. PubMed ID: 10638583
[TBL] [Abstract][Full Text] [Related]
19. Effect of cirrhosis and liver transplantation on the gender difference in QT interval.
Adigun AQ; Pinto AG; Flockhart DA; Gorski JC; Li L; Hall SD; Chalasani N
Am J Cardiol; 2005 Mar; 95(5):691-4. PubMed ID: 15721125
[TBL] [Abstract][Full Text] [Related]
20. QT interval correction in patients with cirrhosis.
Zambruni A; Di Micoli A; Lubisco A; Domenicali M; Trevisani F; Bernardi M
J Cardiovasc Electrophysiol; 2007 Jan; 18(1):77-82. PubMed ID: 17229304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
